Sort
78,016 grants matching “breast cancer”
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$639,256Gerald V Denis · Boston University Medical Campus · R01 · FY2020 · CA
TARGETING POL-THETA AS A NOVEL BREAST CANCER TARGET
$639,255Thomas Jefferson University · · FY2020 · Defense Health Agency
Predicting Breast Cancer Risk after Benign Percutaneous Biopsy
$639,236Mark E Sherman · Mayo Clinic Jacksonville · R01 · FY2022 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$639,231Jay T. Groves · University Of California Berkeley · U01 · FY2016 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$639,231Jay T. Groves · University Of California Berkeley · U01 · FY2018 · CA
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$639,203Ben Shen · Scripps Florida · R01 · FY2019 · CA
Biomarker Detection Using NAPPA Tumor Antigen Arrays
$639,172Joshua Labaer · Arizona State University-Tempe Campus · U01 · FY2011 · CA
Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial
$639,125Diane Marie Von Ah · Ohio State University · R01 · FY2023 · CA
Device for Promoting Survival of Congested Tissue Flaps
$639,098John A. Russell · Spectrocon, Llc · R44 · FY2010 · HL
A physical sciences approach to investigate the role of exosomes in metastatic progression
$639,040Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2024 · CA
ProstaFluor FDA Trial for Real-Time Margin Detection During Prostatectomy
$639,000David A. Benaron · Spectros Corporation · R01 · FY2010 · CA
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers
$638,982Joellen M. Schildkraut · University Of Virginia · R01 · FY2019 · CA
Understanding and Predicting Fatigue, CV Decline & Events After Breast CA Treatment
$638,913William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2016 · CA
CELLULAR AND MOLECULAR RESPONSES TO TARGETED THERAPY
$638,904Wolfgang Michael Korn · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2008 · CA
Resolving the cancer relevance of predisposition gene mutations
$638,814Fergus Joseph Couch · Mayo Clinic Rochester · R35 · FY2024 · CA
HRQoL Values for Cancer Survivors: Enhancing PROMIS Measures for CER
$638,811Benjamin M Craig · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
EXERCISE, DIET, AND SEX HORMONES IN POSTMENOPAUSAL WOMEN
$638,799Anne M McTiernan · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
$638,721Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · U24 · FY2015 · CA
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
$638,683Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA
Determinants of Breast Cancer Survival
$638,634University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica
$638,567Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2013 · CA
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
$638,492Frederick R Appelbaum · University Of Washington · T32 · FY2009 · CA
Community-based HIT Tools for Cancer Screening and Health Insurance Promotion
$638,489Jennifer E Devoe · Oregon Health & Science University · R01 · FY2014 · CA
Local Services Navigation to Improve Breast Cancer Screening Outcomes
$638,481Elissa Mary Ozanne · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
DIGITAL MAMMOGRAPHY HIGH RESOLUTION FLAT PANEL IMAGER
$638,455Univ Of Massachusetts Med Sch Worcester · R01 · FY2001 · CA